Appropriate dosing
Additional charges may apply for optional services or add-ons and the program features and quality may differ
6, President Donald Trump said that Medicare would cover Novo's Wegovy and Lilly's Zepbound for millions of older adults and that the drugmakers would sell discounted versions of the drugs through the federal government's direct-to-consumer website, TrumpRx, which will launch in 2026
Clinical Evidence In a 2021 clinical trial (SURPASS-2), tirzepatide was found to have greater reductions in hemoglobin A1c (HbA1c) and body weight than semaglutide 1 mg in people with type 2 diabetes [6]
Data availability Researchers can request access to data from the TriNetX research network through the TriNetX platform ( However, this may involve associated costs, require a data-sharing agreement, and no patient-identifiable information can be accessible
The data were used under license for this study with restrictions that do not allow for data to be redistributed or made publicly available